Problems of Social Hygiene, Public Health and History of MedicineProblems of Social Hygiene, Public Health and History of Medicine0869-866X2412-2106Joint-Stock Company Chicot104410.32687/0869-866X-2022-30-s1-966-971Научная статьяLITERATURE REVIEW OF GUIDELINES FOR MEDICAL DEVICES ASSESSMENTArkovaE. S.-KuznetsovaYu. A.-KrasnovaL. S.krasnovals@zdrav.mos.ruResearch Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department1511202230s196697117112022Copyright © 2022,2022Background. Research on the development and implementation of new principles and methods applicable in the evaluation of medical devices (MD) will allow to accumulate new, as well as the most effective long-used and proven approaches to the clinical and economic evaluation of such an important and extensive class of medical technologies.Aims. The aim of the study is to identify and analyze developed, approved recommendations for the assessment of MD in the world and domestic practice of assessing health technologies, as well as to find and summarize the current principles, optimal proven and innovative methods for assessing MD for the draft modern recommendations for MD assessment in Moscow.Materials and methods. The sources of the study were scientific articles on the topic of MD assessment and recommendations published over the past five years.Results. A review of publications revealed disunity in the approaches to assessing MD according to international sources, as well as the lack of unified agreed recommendations in Russia. A number of problems and aspects that need to be taken into account when formulating uniform recommendations are clearly defined.Conclusion. It is obvious that there is a need to formulate and adopt clear recommendations on the assessment of medical technologies (HTA) of MD, taking into account positive international experience.medical technology assessmentmedical devicesreview of recommendationsоценка медицинских технологиймедицинские изделияобзор рекомендаций[Холовня-Волоскова М. Э., Толкушин А. Г., Корнилова Е. Б., Завьялов А. А. Сравнительная характеристика видов оценки медицинских технологий // Проблемы социальной гигиены, здравоохранения и истории медицины. 2020. Т. 28, Спецвыпуск. С. 1168-1175. DOI: 10.32687/0869-866X-2020-28-s2-1168-1175][Омельяновский В. В. Основные отличия медицинских изделий от лекарственных препаратов и особенности их исследования // Медицинские технологии. Оценка и выбор. 2013. № 2. С. 42-52.][Арькова Е. С., Лучинин Е. А., Корнилова Е. Б. и др. Основные рекомендации при проведении оценки изделий медицинского назначения - новое в ОМТ // Труды Научно-исследовательского института организации здравоохранения и медицинского менеджмента. М.; 2021. С. 85-90.][Erdös J., Ettinger S., Mayer-Ferbas J. et al. European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices // Wien. Med. Wochenschr. 2019. Vol. 169, N 11-12. P. 284-292. DOI: 10.1007/s10354-019-0684-0][Mayer J., Ettinger S., Nachtnebel A. European collaboration in medical device assessment: one step towards cross-border health care // Gesundheitswesen. 2018. Vol. 80, N 3. P. 210-216. DOI: 10.1055/s-0043-109859][Blüher M., Saunders S. J., Mittard V. et al. Critical review of European health-economic guidelines for the health technology assessment of medical devices // Front. Med. (Lausanne). 2019. Vol. 6. P. 278. DOI: 10.3389/fmed.2019.00278][Kanavos P., Angelis A., Drummond M. An EU-wide approach to HTA: an irrelevant development or an opportunity not to be missed? // Eur. J. Health Econ. 2019. Vol. 20, N 3. P. 329-332. DOI: 10.1007/s10198-019-01037-2][Blankart C. R., Dams F., Penton H. et al. Regulatory and HTA early dialogues in medical devices // Health Policy. 2021. Vol. 125, N 10. P. 1322-1329. DOI: 10.1016/j.healthpol.2021.07.010][Tarricone R., Amatucci F., Armeni P. et al. Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies // Health Policy. 2021. Vol. 125, N 5. P. 602-608. DOI: 10.1016/j.healthpol.2021.03.003][Moore F., Grunch B. H., Miller L. E., Musacchio M. J. Towards a more simplified approach for evaluating strength of evidence in health technology assessments // Cureus. 2021. Vol. 13, N 7. P. e16528. DOI: 10.7759/cureus.16528][Grigore B., Ciani O., Dams F. et al. Surrogate endpoints in health technology assessment: an international review of methodological guidelines // Pharmacoeconomics. 2020. Vol. 38, N 10. P. 1055-1070. DOI: 10.1007/s40273-020-00935-1][Olberg B., Fuchs S., Panteli D. et al. Scientific evidence in health technology assessment reports: an in-depth analysis of european assessments on high-risk medical devices // Value Health. 2017. Vol. 20, N 10. P. 1420-1426. DOI: 10.1016/j.jval.2017.05.011][Polisena J., Castaldo R., Ciani O. et al. Health technology assessment methods guidelines for medical devices: how can we address the gaps? The international federation of medical and biological engineering perspective // Int. J. Technol. Assess Health Care. 2018. Vol. 34, N 3. P. 276-289. DOI: 10.1017/S0266462318000314][Daubner-Bendes R., Kovács S., Niewada M. et al. Quo Vadis HTA for medical devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges // Front. Public Health. 2021. Vol. 8. P. 612410. DOI: 10.3389/fpubh.2020.612410]